<?xml version="1.0" encoding="UTF-8"?>
<p>It was previously shown that COX-2 mRNA increases significantly in the intestinal wall of mice treated with DSS [
 <xref rid="B72-molecules-25-05430" ref-type="bibr">72</xref>]. COX-2 plays a crucial role in intestinal inflammation, one of the main targets of pharmacological therapy for IBDs. The administration of geraniol greatly improved the clinical signs of colitis. It significantly reduced the expression of COX-2 in the colon and, in the intestinal wall, geraniol could be a powerful substance for the treatment of intestinal inflammation and dysbiosis [
 <xref rid="B70-molecules-25-05430" ref-type="bibr">70</xref>].
</p>
